Morgan Stanley
-
-
-
-
-
-
-
Ultragenyx to Participate in Investor Conferences in September
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) PT Lowered to $76 at Morgan Stanley
-
-
-
-
-
-
-
Ultragenyx to Present at Upcoming Investor Conferences
-
-
-
-
-
-
-
Ultragenyx to Present at the Morgan Stanley Global Healthcare Conference
-
-
-
-
-
-
-
Morgan Stanley Downgrades Ultragenyx Pharma (RARE) to Equalweight
-
-
-
-
-
-
-
Ultragenyx Announces Proposed Public Offering of Common Stock
-
-
-
-
-
-
-
Ultragenyx Pharmaceutical (RARE) Announces 2M Common Stock Offering
-
226,934 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

